(Reuters) – The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk’s blockbuster weight-loss drug Wegovy.Here’s what Wall Street analysts say about the inclusion: WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs – the same class of drugs as Ozempic and Wegovy – for people over the age of 65. Medicare prescription … Read more…

By Ernest Scheyder (Reuters) – The U.S. Department of Energy has finalized a $996 million loan for ioneer’s Rhyolite Ridge lithium project, according to documents reviewed by Reuters, an increase of $296 million from a preliminary funding offer and a move aimed at boosting President Joe Biden’s green energy legacy. Shares of ioneer jumped 15% to $4.96 during Friday afternoon trading in New York. Scant U.S. production of lithium, an ultralight metal used to make … Read more…

By Dawn Chmielewski (Reuters) – Businessman Frank McCourt is “open-minded” to keeping TikTok’s existing investors, including the founder, involved after any deal to buy the U.S. operations of the Chinese-owned short-form video app, the U.S. billionaire told Reuters on Thursday. McCourt said in an interview his consortium has made a formal offer to buy TikTok from its Chinese parent company ByteDance, confirming reports that it values the app without its algorithm at around $20 billion. … Read more…

(Reuters) – Microsoft said on Thursday that it is now including Copilot AI features to its Microsoft 365 suite for individual consumers, a day after it rolled out on-demand AI agents for businesses. The Windows-maker will give its customers an option to either choose a Microsoft 365 subscription plan with Copilot AI features or one without it. It will also increase the prices of subscription plans in the U.S. by $3. Copilot will assist users … Read more…

By Patrick Wingrove (Reuters) – Novo Holdings, the controlling shareholder of Novo Nordisk, hopes to double the size of its recently acquired contract drugmaker Catalent over five years, a senior partner at the investment firm said, as it prepares for a likely focus on U.S. manufacturing by President-elect Donald Trump. Novo Holdings last month closed a $16.5 billion deal to buy U.S.-based Catalent. The firm then sold three of Catalent’s plants used to complete the … Read more…

NEW YORK (Reuters) – Goldman Sachs’ credit-card partnership with Apple may end before its contract runs out in 2030, Goldman CEO David Solomon said on Wednesday. “We have a contract with Apple to run that partnership until 2030, although there’s some possibility that it won’t continue until that time frame,” Solomon told analysts on an earnings call. The Apple card dragged down Goldman’s return on equity by 75 to 100 basis points last year, but … Read more…